A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Clinical trial NCT06290128 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06290128
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Polyneuropathy, Inflammatory Demyelinating, Chronic

Start date: 2024-07-12
Primary completion: 2026-06-10
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.